Laura Conti

Medicine & Life Sciences

1. Atrophic Gastritis 100%
2. Neoplasms 86%
3. SARS Virus 75%
4. Lymphocyte Subsets 61%
5. Blood Platelets 61%
6. Serum 60%
7. Antibodies 56%
8. Colorectal Neoplasms 55%
9. Idiopathic Thrombocytopenic Purpura 52%
10. Liquid Biopsy 45%
11. Circulating MicroRNA 45%
12. Prekallikrein Deficiency 42%
13. Multicenter Studies 41%
14. Immunoglobulin G 38%
15. Biomarkers 38%
16. Anemia 37%
17. Syndecan-1 37%
18. Flow Cytometry 37%
19. Blood Cell Count 37%
20. Thrombocytopenia 36%
21. EWS-FLI fusion protein 35%
22. Thymic epithelial tumor 34%
23. Osteosarcoma 34%
24. Vaccines 34%
25. Breast Neoplasms 33%
26. thymic stromal lymphopoietin 32%
27. Viral Antibodies 31%
28. Light 31%
29. Subfamily B ATP Binding Cassette Transporter 31%
30. MicroRNAs 30%
31. Multiple Myeloma 28%
32. Prothrombin 28%
33. Vascular Endothelial Growth Factor A 28%
34. Body Mass Index 26%
35. Ewing's Sarcoma 26%
36. High-Throughput Nucleotide Sequencing 26%
37. Tissue Donors 25%
38. Autoantibodies 25%
39. Ovarian Epithelial Carcinoma 25%
40. Translational Medical Research 24%
41. Cryoglobulinemia 24%
42. Intra-Abdominal Fat 24%
43. Child 24%
44. Autoimmune Diseases 24%
45. Platelet Activation 24%
46. Vaccination 23%
47. Splenectomy 23%
48. Neutralizing Antibodies 23%
49. Pharmaceutical Preparations 23%
50. Cell-Free Nucleic Acids 22%